相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sorafenib Inhibits the Shedding of Major Histocompatibility Complex Class I-Related Chain A on Hepatocellular Carcinoma Cells by Down-Regulating a Disintegrin and Metalloproteinase 9
Keisuke Kohga et al.
HEPATOLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy
Kouichi Momiyama et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients
Jia Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336
Alvaro Moreno-Aspitia et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
Xuyu Zhou et al.
NATURE IMMUNOLOGY (2009)
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
Madeleine M. Hipp et al.
BLOOD (2008)
Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy
Hidenari Nagai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation
W. Zhao et al.
LEUKEMIA (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Natural and TGF-β-induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other
David A. Horwitz et al.
TRENDS IN IMMUNOLOGY (2008)
Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis
Teppei Matsui et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
New therapies for hepatocellular carcinoma
M. A. Avila et al.
ONCOGENE (2006)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Environmental factors and risk for hepatocellular carcinoma
MC Yu et al.
GASTROENTEROLOGY (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Altered maturation of peripheral blood dendritic cells in patients with breast cancer
S Della Bella et al.
BRITISH JOURNAL OF CANCER (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
M Kudo et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Estimating the world cancer burden: GLOBOCAN 2000
DM Parkin et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood
H Jonuleit et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
分享论文
